Medical Market Report

Global Companion Diagnostic Technologies Market By Type (Immunohistochemistry, and Molecular Diagnostics), By Application (Oncology, Cardiovascular, Central Nervous System, Auto immune & Inflammation, Virology, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138381
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Companion Diagnostic Technologies Market is estimated to be valued US$ XX.X million in 2019. The report on Companion Diagnostic Technologies Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global companion diagnostic technologies market is segmented on the basis of Type, Application, and geography.

    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    Companion Diagnostic Technologies Market Scope:

    By type, the market is segmented into Immunohistochemistry, and Molecular Diagnostics. By Application, the market is divided into Oncology, Cardiovascular, Central Nervous System, Auto immune & Inflammation, Virology, and Others.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories Inc., Ventana Medical Systems, bioMerieux, Myriad Genetics Inc., Resonance Health Ltd., Leica Microsystems, and Life Technologies.

    Key Market Segments

    Type

    Immunohistochemistry

    Molecular Diagnostics

    Application

    Oncology

    Cardiovascular

    Central Nervous System

    Auto immune & Inflammation

    Virology

    Others

    Key Market Players included in the report:

    Dako (Agilent Technologies)

    Qiagen

    Roche

    Abbott Laboratories Inc.

    Ventana Medical Systems

    bioMerieux

    Myriad Genetics Inc.

    Resonance Health Ltd.

    Leica Microsystems

    Life Technologies

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Companion Diagnostic Technologies Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Companion Diagnostic Technologies Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Companion Diagnostic Technologies Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Companion Diagnostic Technologies Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Companion Diagnostic Technologies Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Companion Diagnostic Technologies Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Companion Diagnostic Technologies sub-markets, depending on key regions (various vital states).
    To analyze Companion Diagnostic Technologies Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Companion Diagnostic Technologies Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Companion Diagnostic Technologies Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Companion Diagnostic Technologies Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Companion Diagnostic Technologies Market Overview
    

    3.1. Companion Diagnostic Technologies Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Companion Diagnostic Technologies Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Companion Diagnostic Technologies Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Immunohistochemistry
    

      4.4. Molecular Diagnostics
    

    5. Global Companion Diagnostic Technologies Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Companion Diagnostic Technologies Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Oncology
    

      5.4. Cardiovascular
    

      5.5. Central Nervous System
    

      5.6. Auto immune & Inflammation
    

      5.7. Virology
    

      5.8. Others
    

    6. Global Companion Diagnostic Technologies Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Companion Diagnostic Technologies Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Companion Diagnostic Technologies Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Companion Diagnostic Technologies Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Companion Diagnostic Technologies Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Companion Diagnostic Technologies Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Companion Diagnostic Technologies Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Dako (Agilent Technologies)
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. Qiagen
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. Roche
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Abbott Laboratories#Inc.
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. Ventana Medical Systems
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. bioMerieux
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. Myriad Genetics#Inc.
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. Resonance Health Ltd.
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. Leica Microsystems
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

      7.12. Life Technologies
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.